الصحافة

مقالات النشر

عناوين عن الشركات التي نرتبها، المجمعة من مصادر الأخبار العامة. نحن نربط بالمقالة الأصلية ولا نعيد نشرها — علامات المشاعر قائمة على الكلمات المفتاحية، وليس الحكم التحريري.

عرض التغطية الخاصة ب Sanofi S.A.

33 عناوين · 1,721 شركة مغطاة

من 1 إلى 33 من 33

2026-10-21
Sanofi and ScionxBio partner on mRNA therapies - Pharmaceutical Technology
Sanofi S.A.· www.pharmaceutical-technology.com
2026-10-20
Sanofi Drug Option Might Change The Case For Investing In Recursion Stock (RXRX) - Simply Wall Street
Sanofi S.A.· simplywall.st
2026-10-20
ScionxBio Partners with Sanofi on Extended Exposure Versions of mRNA Candidates - Contract Pharma
Sanofi S.A.· www.contractpharma.com
2026-10-20
Sanofi: Why The Market Seems To Be Overpricing Pipeline Risk (NASDAQ:SNY) - Seeking Alpha
Sanofi S.A.· seekingalpha.com
2026-10-20
Sanofi stock: Leerink Partners sets EUR 94.00 target for Sanofi stock - ad-hoc-news.de
Sanofi S.A.· www.ad-hoc-news.de
2026-10-19
Sanofi breaks ground on insulin plant after securing German government support - BioSpace
Sanofi S.A.· www.biospace.com
2026-10-19
ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus Project - PR Newswire
Sanofi S.A.· www.prnewswire.com
2026-10-19
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany - Sanofi
Sanofi S.A.· www.sanofi.com
2026-10-19
Exclusive: Sanofi taps new startup ScionxBio for long-acting RNA - Endpoints News
Sanofi S.A.· endpoints.news
2026-10-19
Sanofi SA (SNW.HA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Sanofi S.A.· uk.finance.yahoo.com
2026-10-19
FR0000140022 Bond Profile: Coupon and Redemption - TradingView
Sanofi S.A.· www.tradingview.com
2026-10-18
Sanofi SA (SNW.HA) stock price, news, quote and history - Yahoo Finance UK
Sanofi S.A.· uk.finance.yahoo.com
2026-10-17
Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share
Sanofi S.A.· fool.com
2026-10-16
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Sanofi S.A.· 247wallst.com
2026-10-15
Regeneron Pharmaceuticals (REGN) Rallies On Earnings Beat As Undervalued Narrative Holds
Sanofi S.A.· finance.yahoo.com
2026-10-15
What Is Sanofi (ENXTPA:SAN) Really Gaining From Wider Canadian Access?
Sanofi S.A.· finance.yahoo.com
2026-10-15
Regeneron (REGN) Stock Still Looks Below Fair Value On Fresh Trial Data
Sanofi S.A.· finance.yahoo.com
2026-10-15
Sanofi (ENXTPA:SAN) Stock Looks Reasonable After Its Antibody Deal
Sanofi S.A.· finance.yahoo.com
2026-10-15
Sector Update: Healthcare Stocks Gain Late Afternoon
Sanofi S.A.· finance.yahoo.com
2026-10-15
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar
Sanofi S.A.· finance.yahoo.com
2026-10-15
Sanofi (ENXTPA:SAN) Adds AI Immunology Candidate As Fair Value Questions Persist
Sanofi S.A.· finance.yahoo.com
2026-10-15
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
Sanofi S.A.· stocktwits.com
2026-10-15
Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal - Benzinga
Sanofi S.A.· www.benzinga.com
2026-10-15
Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care
Sanofi S.A.· finance.yahoo.com
2026-10-15
Sanofi takes corrective dose to end EU antitrust probe - BioWorld News
Sanofi S.A.· www.bioworld.com
2026-10-15
Can Nektar's Pipeline Progress Create Long-Term Value Amid Rivalry?
Sanofi S.A.· finance.yahoo.com
2026-10-15
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
Sanofi S.A.· finance.yahoo.com
2026-10-14
What Could Send Regeneron Stock Higher?
Sanofi S.A.· trefis.com
2026-10-14
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Sanofi S.A.· finance.yahoo.com
2026-10-14
Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine - Reuters
Sanofi S.A.· www.reuters.com
2026-10-14
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
Sanofi S.A.· finance.yahoo.com
2026-10-14
Update: European Commission Accepts Sanofi's Offer to Address Potential Anticompetitive Disparagement of Competing Flu Vaccine
Sanofi S.A.· finance.yahoo.com
2026-10-14
European Commission Accepts Sanofi's Offer to Address Potential Anticompetitive Disparagement of Competing Flu Vaccine
Sanofi S.A.· finance.yahoo.com